Evaluation of FibroTest-ActiTest in children with chronic hepatitis C virus infection

Gastroenterologie Clinique et Biologique

Volumn 34, Issue 1, 2010, Pages 16-22

  Hermeziu, B ^a   Messous, D ^b   Fabre, M ^a   Munteanu, M ^c   Baussan, C ^a   Bernard, O ^a   Poynard, T ^b   Jacquemin, E ^a,d  

^a BICÊTRE HOSPITAL   (France)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c Biopredictive   (France)

^d INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; BILIARY CIRRHOSIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; LIVER BIOPSY; LIVER TRANSPLANTATION; MALE; NON INVASIVE PROCEDURE; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SCORING SYSTEM;

ADOLESCENT; BIOLOGICAL MARKERS; BIOPSY; BLOOD CHEMICAL ANALYSIS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; HEPATITIS C, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; MALE; RETROSPECTIVE STUDIES;

EID: 74349085208     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gcb.2009.06.007     Document Type: Article

References (33)

1. Farinati F., Cardin R., Bortolami M., Burra P., Russo F.P., Rugge M., et al. Hepatitis C virus: from oxygen free radicals to hepatocellular carcinoma. J Viral Hepat 14 (2007) 821-829
2. Jonas M. Children with hepatitis C. Hepatology 36 (2002) S173-S178
3. Bortolotti F., Verucchi V., Camma C., Cabibbo G., Zancan L., Indolfi G., et al. Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease. Gastroenterology 134 (2008) 1900-1907
4. Jara P., Resti M., Hierro L., Giacchino R., Barbera C., Zancan L., et al. Chronic hepatitis C virus infection in childhood: clinical patterns and evolution in 224 white children. Clin Infect Dis 36 (2003) 275-280
5. González-Peralta R.P., Kelly D.A., and Haber B. Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: efficacy, safety, and pharmacokinetics. Hepatology 42 (2005) 1010-1018
6. Wirth S., Pieper-Boustani H., Lang T., Ballauff A., Kullmer U., Gerner P., et al. Peginterferon alfa-2b plus ribavirin treatment in children and adolescents with chronic hepatitis C. Hepatology 41 (2005) 1013-1018
7. Poynard T., Imbert-Bismut F., Munteanu M., Messous D., Myers R.P., Thabut D., et al. Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C. Comp Hepatol 23 3 (2004) 8
8. Fontana R.J., and Lok A.S. Noninvasive monitoring of patients with chronic hepatitis C. Hepatology 36 (2002) S57-S64
9. Shaheen A.A., Wan A.F., and Myers R.P. FibroTest and FibroScan for the prediction of hepatitis C-related fibrosis: a systematic review of diagnostic test accuracy. Am J Gastroenterol 102 (2007) 2589-2600
10. Fontaine H., Petitprez K., Roudot-Thoraval F., and Trinchet J.C. Guidelines for the diagnosis of uncomplicated cirrhosis. Gastroenterol Clin Biol 31 (2007) 504-509
11. Rossi E., Adams L., Prins A., Bulsara M., de Boer B., Garas G., et al. Validation of the FibroTest biochemical markers score in assessing liver fibrosis in hepatitis C patients. Clin Chem 49 (2003) 450-454
12. Poynard T., Morra R., Halfon P., Castera L., Ratziu V., Imbert Bismut F., et al. Meta-analyses of Fibrotest diagnostic value in chronic liver disease. BMC Gastroenterol 15 (2007) 40
13. Ngo Y., Munteanu M., Messous D., Charlotte F., Imbert-Bismut F., Thabut D., et al. A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C. Clin Chem 52 (2006) 1887-1896
14. Myers R.P., Ratziu V., Imbert-Bismut F., Charlotte F., and Poynard T. Biochemical markers of liver fibrosis: a comparison with historical features in patients with chronic hepatitis C. Am J Gastroenterol 97 (2002) 2419-2425
15. Poynard T., Imbert-Bismut F., Ratziu V., Chevret S., Jardel C., Moussalli J., et al. Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial. J Viral Hepat 9 (2002) 128-133
16. Imbert-Bismut F., Ratziu V., Pieroni L., Charlotte F., Benhamou Y., and Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 357 (2001) 1069-1075
17. Leroy V., Hilleret M.N., Sturm N., Trocme C., Renversez J.C., Faure P., et al. Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C. J Hepatol 46 (2007) 775-782
18. Zarski J.P., Bedossa P., Bronowicki J.P., Doffoel M., and Poynard T. Non invasive markers using for the assessment of fibrosis in hepatitis C. Gastroenterol Clin Biol 31 4 (2007) S34-S39
19. Halfon P., Bacq Y., De Muret A., Penaranda G., Bourliere M., Ouzan D., et al. Comparison of test performance profile for blood tests of liver fibrosis in chronic hepatitis C. J Hepatol 46 (2007) 395-402
20. de Lédinghen V., Le Bail B., Rebouissoux L., Fournier C., Foucher J., Miette V., et al. Liver stiffness measurement in children using FibroScan: Feasibility study and comparison with Fibrotest, Aspartate Transaminase to Platelets Ratio Index, and liver biopsy. J Pediatr Gastroenterol Nutr 45 (2007) 443-450
21. Imbert-Bismut F., Messous D., Thibault V., Myers R.B., Piton A., Thabut D., et al. Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors. Clin Chem Lab Med 42 (2004) 323-333
22. Camarero C., Ramos N., Moreno A., Asensio A., Mateos M.L., and Roldan B. Hepatitis C virus infection acquired in childhood. Eur J Pediatr 167 (2008) 219-224
23. Messous D., Munteanu M., Morra R., Piton A., Poynard T., Hainque B., et al. Time impact of serum storage temperature on stability of important liver enzymes and proteins and on FibroTest-ActiTest results. Clinica Chimica Acta 335 (2005) 400
24. Poynard T., Munteanu M., Imbert-Bismut F., Charlotte F., Thabut D., Le Calvez S., et al. Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C. Clin Chem 50 (2004) 1344-1355
25. Cadranel J.F., Rufat P., and Degos F. Practices of liver biopsy in France: results of a prospective nationwide survey. For the Group of Epidemiology of the French Association for the Study of the Liver (AFEF). Hepatology 32 (2000) 477-481
26. Bedossa P., Dargère D., and Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 38 (2003) 1449-1457
27. Colloredo G., Guido M., Sonzogni A., and Leandro G. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol 39 (2003) 239-244
28. Guido M., and Rugge M. Liver biopsy sampling in chronic viral hepatitis. Semin Liver Dis 24 (2004) 89-97
29. Grigorescu M., Rusu M., Neculoiu D., Radu C., Serban A., Catanas M., et al. The FibroTest value in discriminating between insignificant and significant fibrosis in chronic hepatitis C patients. The Romanian experience. J Gastrointestin Liver Dis 16 (2007) 31-37
30. De Ledinghen V., and Vergniol J. Transient elastography (FibroScan). Gastroenterol Clin Biol 32 Suppl 1 (2008) 58-67
31. Le Calvez S., Thabut D., Messous D., Munteanu M., Ratziu V., Imbert-Bismut F., et al. The predictive value of Fibrotest vs. APRI for the diagnosis of fibrosis in chronic hepatitis C. Hepatology 39 (2004) 862-863
32. Calès P., Oberti F., Michalak S., Hubert-Fouchard I., Rousselet M.C., Konaté A., et al. A novel panel of blood markers to assess the degree of liver fibrosis. Hepatology 42 (2005) 1373-1381
33. Lamireau T., Franchi S., Fabre M., Le Bail B., Chateil J.F., Pariente D., et al. A dedicated Fibroscan probe to evaluate liver fibrosis in children : feasibility and performance for the diagnosis of cirrhosis. Hepatology 46-44S1 (2007) 277A [abstract]